glp 1 agonist dpp 4 inhibitor DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Cardiovascular effects of DPP-4 inhibition:
Description
Its not about having the best data as you progress your asset through its development cycle, its understanding and planning the strategic moves you need to make to maximise your opportunity, widening your focus and ensuring you have a position to dominate

Couzin-Frankel 6 Sept 2023

The ROR metric serves as a quantitative indicator of the strength of association between the target drug and specific adverse events (AEs), with elevated ROR values denoting stronger statistical associations

Drug repositioning could indeed present several advantages as compared to the development of a new drug

Results One of the central outcomes of this study was to understand the influence of allulose on altering body weight changes and food consumption, including adding to the mediating mechanisms of such changes
The mean BMI z score decreased by 0.41 (95% CI: 0.57 to 0.25
